BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 18593250)

  • 1. Pharmacokinetics and clinical effects of pirfenidone administered intravenously in horses.
    Braim AE; Macdonald MH; Bruss ML; Stanley SD; Giri JK; Giri SN
    Am J Vet Res; 2008 Jul; 69(7):952-60. PubMed ID: 18593250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intravenous administration of pirfenidone on horses with experimentally induced endotoxemia.
    Poulin Braim AE; MacDonald MH; Bruss ML; Grattendick KJ; Giri SN; Margolin SB
    Am J Vet Res; 2009 Aug; 70(8):1031-42. PubMed ID: 19645586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of epsilon-aminocaproic acid in horses.
    Ross J; Dallap BL; Dolente BA; Sweeney RW
    Am J Vet Res; 2007 Sep; 68(9):1016-21. PubMed ID: 17764418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and metabolism of intravenous pirfenidone in sheep.
    Bruss ML; Stanley SD; Margolin SB; Giri SN
    Biopharm Drug Dispos; 2008 Mar; 29(2):119-26. PubMed ID: 18176939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and clinical effects of a subanesthetic continuous rate infusion of ketamine in awake horses.
    Fielding CL; Brumbaugh GW; Matthews NS; Peck KE; Roussel AJ
    Am J Vet Res; 2006 Sep; 67(9):1484-90. PubMed ID: 16948590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and effects of aminorex in horses.
    Soma LR; Rudy JA; Uboh CE; Xu F; Snapp HM
    Am J Vet Res; 2008 May; 69(5):675-81. PubMed ID: 18447801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and metabolism of a novel antifibrotic drug pirfenidone, in mice following intravenous administration.
    Giri SN; Wang Q; Xie Y; Lango J; Morin D; Margolin SB; Buckpitt AR
    Biopharm Drug Dispos; 2002 Jul; 23(5):203-11. PubMed ID: 12116052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic effects and pharmacokinetic profile of a long-term continuous rate infusion of racemic ketamine in healthy conscious horses.
    Lankveld DP; Driessen B; Soma LR; Moate PJ; Rudy J; Uboh CE; van Dijk P; Hellebrekers LJ
    J Vet Pharmacol Ther; 2006 Dec; 29(6):477-88. PubMed ID: 17083451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of the calcium-channel blocker diltiazem after a single intravenous dose in horses.
    Schwarzwald CC; Sams RA; Bonagura JD
    J Vet Pharmacol Ther; 2006 Jun; 29(3):165-71. PubMed ID: 16669860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single- and multiple-dose pharmacokinetics of pirfenidone, an antifibrotic agent, in healthy Chinese volunteers.
    Shi S; Wu J; Chen H; Chen H; Wu J; Zeng F
    J Clin Pharmacol; 2007 Oct; 47(10):1268-76. PubMed ID: 17906160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and plasma concentrations of acetylsalicylic acid after intravenous, rectal, and intragastric administration to horses.
    Broome TA; Brown MP; Gronwall RR; Casey MF; Meritt KA
    Can J Vet Res; 2003 Oct; 67(4):297-302. PubMed ID: 14620867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of multiple-dose administration of eltenac in horses.
    Dyke TM; Sams RA; Thompson KG; Ashcraft SM
    Am J Vet Res; 1998 Nov; 59(11):1447-50. PubMed ID: 9829405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ibuprofen after intravenous and oral administration and assessment of safety of administration to healthy foals.
    Breuhaus BA; DeGraves FJ; Honore EK; Papich MG
    Am J Vet Res; 1999 Sep; 60(9):1066-73. PubMed ID: 10490073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of ketoprofen in healthy foals less than twenty-four hours old.
    Wilcke JR; Crisman MV; Scarratt WK; Sams RA
    Am J Vet Res; 1998 Mar; 59(3):290-2. PubMed ID: 9522947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline and dyphylline pharmacokinetics in the horse.
    Ayres JW; Pearson EG; Riebold TW; Chang SF
    Am J Vet Res; 1985 Dec; 46(12):2500-6. PubMed ID: 4083583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.
    De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P
    Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of flunixin meglumine injectable preparation administered orally to healthy horses.
    Pellegrini-Masini A; Poppenga RH; Sweeney RW
    J Vet Pharmacol Ther; 2004 Jun; 27(3):183-6. PubMed ID: 15189304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic evaluation of tissue distribution of pirfenidone and its metabolites for idiopathic pulmonary fibrosis therapy.
    Togami K; Kanehira Y; Tada H
    Biopharm Drug Dispos; 2015 May; 36(4):205-15. PubMed ID: 25487063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of difloxacin after intravenous, intramuscular, and intragastric administration to horses.
    Fernández-Varón E; Cárceles CM; Marín P; Martos N; Escudero E; Ayala I
    Am J Vet Res; 2006 Jun; 67(6):1076-81. PubMed ID: 16740105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.